Research on the mechanism of the active ingredients of Sanchi and Gardenia removing the early amyloid in the AD transgenic mouse brain

Chinese Pharmacological Bulletin

Volumn 28, Issue 2, 2012, Pages 173-179

  Zhang, Ying ^a   Lin, Sen Xiang ^a   Hua, Qian ^a   Yang, Kai Yu ^a   Yao, Na ^a   Yi, Liu Shu ^a   Wang, Ai Min ^a   Chen, Wen Ju ^a   Chen, Jin Yan ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Alzheimer's disease; Amyloid; Gardenia; IDE; NEP; Sanchi

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GARDENIA EXTRACT; GENIPOSIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GARDENIA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SANCHI; TRANSGENIC MOUSE; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 84860310559     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2012.02.007     Document Type: Article

References (15)

1. Yamin G, Ono K, Inayathullah M, Teplow D B. Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease[J]. Curr Pharm Des, 2008,14(30):3231-46.
2. La Ferla F M, Green K N, Oddo S. Intracellular amyloid-beta in Alzheimer's disease[J]. Nat Rev: Neurosc, 2007,8(7):499-509.
3. De Strooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein[J]. Nature, 1998,391:387-90. (Pubitemid 28093512)
4. Pérez A, Morelli L, Cresto J C, et al. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains[J]. Neurochem Res, 2000,25(2):247-55. (Pubitemid 30210091)
5. Kurochkin I V, Goto S. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme[J]. FEBS Lett, 1994,345(1):33-7.
6. McDermott J R, Gibson A M. Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme[J]. Neurochem Res, 1997,22(1):49-56.
7. Mukherjee A, Song E S, Kihiko M, et al. Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques[J]. J Neurosci, 2000,20(23):8745-9.
8. Miller B C, Eckman E A, Sambamurti K, et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo[J]. Proc Natl Acad Sci USA, 2003,100(10):6221-6. (Pubitemid 36576957)
9. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo[J]. Proc Natl Acad Sci USA, 2003,100(7):4162-7. (Pubitemid 36418174)
10. Turner A J, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX[J]. FASEB J, 1997,11(5):355-64. (Pubitemid 27193940)
11. Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Abeta by neprilysin[J]. Science, 2001,292(5521):1550-2. (Pubitemid 32493424)
12. Yasojima K, Akiyama H, McGeer E G, et al. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide[J]. Neurosci Lett, 2001,297(2):97-100.
13. Liu Y, Hua Q, Lei H T, Li P T. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains[J]. J Ethnopharmacol, 2011,137(2):1035-46.
14. Qin C, Zhu H, Zhang B L, et al. Pathomorphological and Immunohistochemical Findings in Brains of APP Transgenic Model[J]. Acta Lab Animal Sci Sin, 2000,8(4):213.
15. Qin C, Zhu H, Chang Y, et al. The Behavior evaluation on transgenic mice of Alzheimer's disease[J]. Shanghai Lab Animal Sci, 2000,20(4):210.